VXX Stock News 36.55 05/18/2014 19:00:02 VIX Short-Term Futures

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VIX Short-Term Futures ETN Ipath (VXX) 36.55 $VXX

After Yesterday's Decline of 2.32%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 16, 3:42PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $36.54 to a high of $37.56. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $36.67 on volume of 27.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Rebound After Yesterday's Selloff of 2.32%
Comtex SmarTrend(R) - Fri May 16, 3:42PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $36.54 to a high of $37.56. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $36.67 on volume of 27.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Barclays Bank PLC to De-List Nine Canada-Listed ETNs
Business Wire - Thu May 15, 5:50PM CDT
Barclays Bank PLC ("Barclays" announced today that it has elected to de-list the following nine iPath(R) exchange traded notes (ETNs) from the Toronto Stock Exchange (TSX):

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 2.98% Yesterday
Comtex SmarTrend(R) - Mon May 12, 3:46PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $37.02 to a high of $37.94. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $38.23 on volume of 23.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 1.10% Yesterday
Comtex SmarTrend(R) - Mon May 05, 4:02PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $39.55 to a high of $40.85. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $39.73 on volume of 22.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 1.10% Sell Off
Comtex SmarTrend(R) - Mon May 05, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $39.55 to a high of $40.85. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $39.73 on volume of 22.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Rebound After Yesterday's Selloff of 1.83%
Comtex SmarTrend(R) - Tue Apr 29, 3:39PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.15 to a high of $40.91. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $40.72 on volume of 25.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Falls 1.85% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 21, 3:46PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.85 to a high of $41.73. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $41.62 on volume of 21.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.85%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Apr 21, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.85 to a high of $41.73. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $41.62 on volume of 21.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Falls 3.57% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Apr 16, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.28 to a high of $43.71. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $43.33 on volume of 33.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 3.57% Sell Off
Comtex SmarTrend(R) - Wed Apr 16, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.28 to a high of $43.71. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $43.33 on volume of 33.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Rally of 6.00% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Apr 10, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.96 to a high of $43.60. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of $43.41 on volume of 47.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 Signs the Dow's Drop Is Just a Dip
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 07, 8:03PM CDT
The Dow Jones Industrials fell 166 points Monday, following up on Friday's similar losses and getting many investors fearful about the future of stocks. With the popular "sell in May" indicator just a few weeks away from triggering its seasonal...

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Pullback After Yesterday's Rally of 2.07%
Comtex SmarTrend(R) - Fri Apr 04, 3:43PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.25 to a high of $42.36. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $42.06 on volume of 48.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Don't Let These ETFs Fool You - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Tue Apr 01, 10:45AM CDT
Most ETFs are simple and transparent but investors need to be aware of a few potential pitfalls with some ETFs.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 13

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 243

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 11

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 176

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 464

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 39

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 82

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 43

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 74

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading

Top 5 Most Recently Viewed Articles

Topicus.com Reports Q3 2025 Financial Results with Growth

Updated Category News Views 757

Financial Overview of Topicus.com Inc. for Q3 2025 In a significant financial announcement, Topicus.com Inc. (TSXV: TOI), in conjunction with Constellation Software Inc. (TSX: CSU), has shared their results for the third quarter of 2025. For the quarter ending on September 30, 2025, the total revenue reached €387.9 million, which reveals an impressive 24% increase from...

Continue Reading
First Financial Security, Inc. Executes a Strategic 10-for-1 Stock Split

Updated Category News Views 266

Strategic 10-for-1 Stock Split Announcement by First Financial Security, Inc. First Financial Security, Inc. (FFS) has recently announced a significant corporate action — a 10-for-1 stock split of its authorized shares of common stock. This adjustment is a clear indication of the company’s positive growth outlook and its unwavering commitment to providing enhanced...

Continue Reading
Octopus AIM VCT plc Reports Strong Net Asset Value Update

Updated Category News Views 55

Overview of Octopus AIM VCT plc Octopus AIM VCT plc is a distinguished investment firm known for its focus on investments in AIM-listed companies. The firm aims to provide investors with significant returns through its carefully managed portfolio, making it a key player in the investment landscape. With a commitment to transparency and value, Octopus AIM VCT plc regularly...

Continue Reading
Revolt CBD Shows Innovation and Growth in Its Latest Update

Updated Category News Views 180

Revolt CBD Launches Innovative Website Redesign In a significant move towards enhancing customer engagement, Revolt CBD has officially unveiled its newly redesigned website. This development marks a pivotal moment for the brand as it strives to improve accessibility, transparency, and innovation in 2026. The new online platform is designed to better reflect the brand's...

Continue Reading
Strategic Merger to Enhance Biopharmaceutical Innovations

Updated Category News Views 86

Exciting Merger Between ACELYRIN and Alumis The proposed merger between ACELYRIN, INC. (Nasdaq: SLRN) and Alumis Inc. marks a pivotal moment in the biopharma landscape focused on immune-mediated diseases. This partnership is set to create a robust clinical stage company, combining strengths and resources to deliver transformative treatment options to patients. Key...

Continue Reading